ロード中...
Clinical outcome measures for Cutaneous Lupus Erythematosus
Cutaneous lupus erythematosus is a clinically heterogeneous group of rare skin diseases that only rarely have been subjected to controlled clinical trials. This may be have been partly due to a lack of suitable validated outcome instruments. Recently the FDA mandated that organ specific trials for l...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3081505/ https://ncbi.nlm.nih.gov/pubmed/20693208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0961203310370049 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|